Cyclosporine and hyperoxia-induced lung damage in neonatal rats

Respiratory Physiology and Neurobiology

Volumn 187, Issue 1, 2013, Pages 41-46

  Porzionato, Andrea ^a   Zaramella, Patrizia ^a   Macchi, Veronica ^a   Sarasin, Gloria ^a   Di Giulio, Camillo ^b   Rigon, Antonella ^a   Grisafi, Davide ^a   Dedja, Arben ^a   Chiandetti, Lino ^a   De Caro, Raffaele ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Bronchopulmonary dysplasia; CD31; Development; Prematurity

Indexed keywords

CYCLOSPORIN;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; CAPILLARY DENSITY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HYPEROXIA; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS; LUNG DYSPLASIA; LUNG INJURY; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; ANIMALS, NEWBORN; BRONCHOPULMONARY DYSPLASIA; CYCLOSPORINE; DISEASE MODELS, ANIMAL; FEMALE; HYPEROXIA; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG INJURY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84877924983     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2013.02.018     Document Type: Review

References (28)

1. American Academy of Pediatrics Committee on Drugs Transfer of drugs and other chemicals into human milk. Pediatrics 2001, 108:776-789.
2. Balasubramaniam V., Mervis C.F., Maxey A.M., Markham N.E., Abman S.H. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. American Journal of Physiology - Lung Cellular and Molecular Physiology 2007, 292:L1073-L1084.
3. Bancalari E., Claure N., Sosenko I.R. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Seminars in Neonatology 2003, 8:63-71.
4. Böhmer A.E., Mendes Ribeiro Corrêa A., de Souza D.G., Knorr L., Hansel G., Corbellini L.G., Driemeier D., Portela L.V., Souza D.O. Long-term cyclosporine treatment: evaluation of serum biochemical parameters and histopathological alterations in Wistar rats. Experimental and Toxicologic Pathology 2011, 63:119-123.
5. Dauger S., Ferkdadji L., Saumon G., Vardon G., Peuchmaur M., Gaultier C., Gallego J. Neonatal exposure to 65% oxygen durably impairs lung architecture and breathing pattern in adult mice. Chest 2003, 123:530-538.
6. Felton V.M., Inge L.J., Willis B.C., Bremner R.M., Smith M.A. Immunosuppression-induced bronchial epithelial-mesenchymal transition: a potential contributor to obliterative bronchiolitis. Journal of Thoracic and Cardiovascular Surgery 2011, 141:523-530.
7. Gill R.S., Lee T.F., Liu J.Q., Chaudhary H., Brocks D.R., Bigam D.L., Cheung P.Y. Cyclosporine treatment reduces oxygen free radical generation and oxidative stress in the brain of hypoxia-reoxygenated newborn piglets. PLoS ONE 2012, 7:e40471.
8. Grisafi D., Tassone E., Dedja A., Oselladore B., Masola V., Guzzardo V., Porzionato A., Salmaso R., Albertin G., Artusi C., Zaninotto M., Onisto M., Milan A., Macchi V., De Caro R., Fassina A., Bordigato M.A., Chiandetti L., Filippone M., Zaramella P. L-citrulline prevents alveolar and vascular derangement in a rat model of moderate hyperoxia-induced lung injury. Lung 2012, 190:419-430.
9. Han S.Y., Mun K.C., Choi H.J., Kwak C.S., Bae J.H., Suh S.I., Park S.B., Kim H.C., Chang E.J. Effects of cyclosporine and tacrolimus on the oxidative stress in cultured mesangial cells. Transplantation Proceedings 2006, 38:2240-2241.
10. Jeon D.S., Ha E.Y., Mun K.C. Effects of cyclosporine on oxidative stress in human bronchial epithelial cells. Transplantation Proceedings 2012, 44:988-990.
11. Kwak C.S., Mun K.C., Suh S.I. Production of oxygen free radicals and of hemolysis by cyclosporine. Transplantation Proceedings 2002, 34:2654-2655.
12. Matthew E., Kutcher L., Dedman J. Protection of lungs from hyperoxic injury: gene expression analysis of cyclosporin A therapy. Physiological Genomics 2003, 14:129-138.
13. Matthew E., Pun R., Simonich M., Iwamoto H., Dedman J. Cyclosporin A protects lung function from hyperoxic damage. American Journal of Physiology 1999, 276:L786-L795.
14. Minoo P., King R.J., Coalson J.J. Surfactant proteins and lipids are regulated independently during hyperoxia. American Journal of Physiology 1992, 263:L291-L298.
15. Moretti M.E., Sgro M., Johnson D.W., Sauve R.S., Woolgar M.J., Taddio A., Verjee Z., Giesbrecht E., Koren G., Ito S. Cyclosporine excretion into breast milk. Transplantation 2003, 75:2144-2146.
16. Mun K.C., Lee K.T., Choi H.J., Jin K.B., Han S.Y., Park S.B., Kim H.C., Ha E.Y., Kim Y.H. Effects of cyclosporine on the production of the reactive oxygen species in the glial cells. Transplantation Proceedings 2008, 40:2742-2743.
17. Munoz-Flores-Thiagarajan K.D., Easterling T., Davis C., Bond E.F. Breast-feeding by a cyclosporine-treated mother. Obstetrics & Gynecology 2001, 97:816-818.
18. Nyberg G., Haljamäe U., Frisenette-Fich C., Wennergren M., Kjellmer I. Breast-feeding during treatment with cyclosporine. Transplantation 1998, 65:253-255.
19. Osadchy A., Koren G. Cyclosporine and lactation: when the mother is willing to breastfeed. Therapeutic Drug Monitoring 2011, 33:147-148.
20. Pagano A., Donati Y., Métrailler I., Barazzone Argiroffo C. Mitochondrial cytochrome c release is a key event in hyperoxia-induced lung injury: protection by cyclosporin A. American Journal of Respiratory and Critical Care Medicine 2004, 286:L275-L283.
21. Pazetti R., Pego-Fernandes P.M., Ranzani O.T., Parra E.R., Lorenzi-Filho G., Jatene F.B. Cyclosporin A reduces airway mucus secretion and mucociliary clearance in rats. Clinics 2007, 62:345-352.
22. Porzionato A., Macchi V., Parenti A., De Caro R. The distribution of mast cells in the human area postrema. Journal of Anatomy 2004, 204:141-147.
23. Randell S.H., Mercer R.R., Young S.L. Postnatal growth of pulmonary acini and alveoli in normal and oxygen-exposed rats studied by serial section reconstructions. American Journal of Anatomy 1989, 186:55-68.
24. Roos P.J., van Gent C.M., Mauch J.C., Blankenship J.W., Bailey L.L., Sandberg L.B. Modification of the pulmonary connective tissue developmental response in the neonatal rat by cyclosporin. Developmental Pharmacology and Therapeutics 1991, 16:89-98.
25. Schittny J.C., Mund S.I., Stampanoni M. Evidence and structural mechanism for late lung alveolarization. American Journal of Physiology - Lung Cellular and Molecular Physiology 2008, 294:L246-L254.
26. Sharpe R.J., Arndt K.A., Bauer S.I., Maione T.E. Cyclosporine inhibits basic fibroblast growth factor-driven proliferation of human endothelial cells and keratinocytes. Archives of Dermatology 1989, 125:1359-1362.
27. Slattery C., Campbell E., McMorrow T., Ryan M.P. Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. American Journal of Pathology 2005, 167:395-407.
28. Thebaud B., Abman S.H. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. American Journal of Respiratory and Critical Care Medicine 2007, 175:978-985.